Latest Lead News

Cann Group Limited has opened a $6.5 million Share Purchase Plan (SPP) alongside a placement, offering shareholders discounted shares with attaching options as it targets significant revenue growth in FY26.

Universal Store Holdings has reported robust FY25 results with revenue climbing 15.5% to $333.3 million and a dividend increase, signaling confidence despite retail headwinds. Early FY26 trading shows continued momentum.

Cann Group Limited (ASX, CAN) launches a $2.5 million Share Purchase Plan offering eligible shareholders discounted shares and attaching options, supporting its recent debt restructure and growth ambitions.

Universal Store Holdings reports a robust 13.7% rise in direct-to-customer sales for FY26 YTD, driven by strong brand performances and a strategic store rollout plan.

Conico Ltd updates shareholders on a significant capital raising expansion, including a share consolidation and converting loan conversions to fund exploration at Mount Thirsty.

Medallion Metals has executed a binding agreement to acquire the Forrestania Nickel Operation from IGO, expanded its Ravensthorpe gold-copper resource to nearly 1 million ounces gold equivalent, and secured a $50 million prepayment facility with Trafigura to advance project development.

Arovella Therapeutics reported solid progress in Q1 FY26, moving closer to initiating its first-in-human trial for ALA-101 while securing key patents and maintaining a strong cash position.

Norwest Minerals advances its Bulgera Gold Project with successful deep drilling and promising heap leach economics, while preparing to test historic gold targets at Marymia East and expanding base metals exploration at Arunta West.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Kuniko Limited has executed a binding earn-in agreement for a major Australian gold-silver project and raised A$2.7 million to fund exploration, while progressing its Norwegian battery metals portfolio.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Iltani Resources has announced its first JORC Mineral Resource Estimate for the Orient East Silver-Indium deposit, significantly expanding the total resource base of its Orient Project in Northern Queensland.